This should start the shorters heading for the exit, if they have any sense. I can't imagine that WES will be happy with just KDR if they want to stake out a big claim in the battery space.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%